Breaking News, Trials & Filings

Trials & Filings in Brief: Dec. 16, 2013

Alcobra, Alnylam, BioLineRx, Cubist, Gilead, La Jolla, NeoStem, PharmAthene, Recipharm, Shield

By: Gil Roth

President, Pharma & Biopharma Outsourcing Association

Phase II Alcobra posts adult ADHD results . . . read more Alnylam begins subcutaneous ATTR treatment trial . . . read more Initial results in for BioLineRx AML trial . . . read more La Jolla begins CKD trial . . . read more NeoStem completes enrollment in CV trial . . . read more Phase III Cubist posts topline results from cIAI trial . . . read more Filings Gilead Complera one-tab HIV regimen approved for new patient group . . . read more PharmAthene trial placed on clinical hold . . . re...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters